ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
APC | Adenomatous polyposis coli | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ATM | Ataxia telangiectasia mutated | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
AXIN1 | Axin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
BCL6 | B-cell CLL/lymphoma 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
BRAF | V-raf murine sarcoma viral oncogene homolog B | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CARD11 | Caspase recruitment domain family, member 11 | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes
| | | | | Mixed |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CDC73 | Cell division cycle 73 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDK12 | Cyclin-dependent kinase 12 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CIC | Capicua transcriptional repressor | Cancer-related genes Transcription factors
| | | | | Expressed in all |
CNOT3 | CCR4-NOT transcription complex, subunit 3 | Cancer-related genes
| | | | | Expressed in all |
CREBBP | CREB binding protein | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
DAXX | Death-domain associated protein | Cancer-related genes
| | | | | Expressed in all |
DDB2 | Damage-specific DNA binding protein 2, 48kDa | Cancer-related genes Disease related genes
| | | | | Expressed in all |
DNM2 | Dynamin 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ERCC4 | Excision repair cross-complementing rodent repair deficiency, complementation group 4 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ERCC5 | Excision repair cross-complementing rodent repair deficiency, complementation group 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EZH2 | Enhancer of zeste homolog 2 (Drosophila) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Mixed |
FANCG | Fanconi anemia, complementation group G | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FH | Fumarate hydratase | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
FLCN | Folliculin | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FOXA1 | Forkhead box A1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
GATA1 | GATA binding protein 1 (globin transcription factor 1) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
GATA2 | GATA binding protein 2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
H3F3A | H3 histone, family 3A | Cancer-related genes
| | | | | Expressed in all |
H3F3B | H3 histone, family 3B (H3.3B) | Cancer-related genes
| | | | | Expressed in all |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KDR | Kinase insert domain receptor (a type III receptor tyrosine kinase) | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KLF4 | Kruppel-like factor 4 (gut) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
KLF6 | Kruppel-like factor 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |